To continue reading this article, you must have a paid membership.
Existing paying members, please log in to access the full story.
If you are not a paying member, sign up now:
GOJO takes action after FDA letter
US jan/san manufacturer GOJO responded swiftly to a warning letter from the US Food and Drug Administration (FDA) in January.
